23andMe Holding Co.
ME
$2.47
-$0.135-5.19%
Rating Factors
Growth Index
Efficiency Index
--
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/7/2023
-
Ticker Report
2/1/2023
-
Insider Monkey
1/26/2023
-
Globe Newswire
1/25/2023
-
Fool.com Headlines
1/3/2023
-
Zolmax
12/22/2022
-
Simply Wall St
12/20/2022
-
Zolmax
12/20/2022
-
Ticker Report
12/19/2022
-
Zolmax
12/18/2022
-
Ticker Report
12/16/2022
-
MINING.com
12/15/2022
-
InvestorPlace
12/10/2022
-
Ticker Report
12/10/2022
-
Zolmax
12/8/2022
-
Ticker Report
12/8/2022
-
Zolmax
12/5/2022
-
Benzinga
12/1/2022
-
Globe Newswire
12/1/2022
-
ETF Channel
11/26/2022
-
Ticker Report
11/26/2022
-
ZDNet Latest News
11/17/2022
-
Insider Monkey
11/17/2022
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 7, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Feb 6 and 10 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 938 6300
Address
349 Oyster Point Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Industry
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment...
more
